CANADA LIFE ASSURANCE Co
InsurancePosition in EDIT — Editas Medicine, Inc.
CIK 1046192
WINNIPEG, A2
Position in EDIT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$142,600
+$50,168 QoQ
Shares Held
57,733
+28.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,124,718 across 78 Biotechnology names. EDIT ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in EDIT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $142,600 | 57,733 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $92,432 | 45,089 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $158,766 | 45,754 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $70,263 | 31,938 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,773 | 8,425 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,063 | 7,137 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $58,679 | 17,208 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $93,759 | 20,077 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $322,829 | 43,508 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $423,687 | 41,825 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $153,090 | 19,627 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $101,418 | 12,323 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $69,542 | 9,592 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $37,511 | 4,229 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $48,862 | 3,992 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $70,545 | 3,709 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $95,261 | 3,588 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $142,711 | 3,474 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $196,767 | 3,474 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $175,014 | 4,167 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $292,148 | 4,167 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $116,926 | 4,167 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $123,259 | 4,167 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $58,895 | 2,970 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||